Guillaume Eppe

Guillaume Eppe has extensive experience in medicinal chemistry, currently serving as Team Leader at Evotec since July 2015, after progressing from Research Scientist and Research Associate roles within the same company. Prior to Evotec, Guillaume held the position of Scientist in Medicinal Chemistry focused on Neurosciences at Janssen, Pharmaceutical Companies of Johnson and Johnson from September 2014 to June 2015. A postdoctoral researcher at Technion - Israel Institute of Technology from December 2012 to September 2014, Guillaume specialized in stereoselective synthesis, particularly studying the activation of C-C bonds in the synthesis of chiral structures. Education includes a PhD in Synthetic Bioorganic Chemistry and an MSc in Synthetic Organic Chemistry, both from Université de Namur.